Rappahannock General Hospital is a clinical research site located in Kilmarnock, Virginia, United States 22482.
Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Rappahannock General Hospital has participated in 6 clinical trials.
Therapeutic areas: Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma.
Sponsors: National Cancer Institute (NCI), NSABP Foundation Inc, Radiation Therapy Oncology Group.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Virginia · View every site in Kilmarnock
Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rappahannock General Hospital has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rappahannock General Hospital has 6 clinical trials on record. Their work covers Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma.
Rappahannock General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.